Role of endogenous sleep-wake and analgesic systems in anesthesia

Journal of Comparative Neurology

Volumn 508, Issue 4, 2008, Pages 648-662

  Lu, Jun ^a,c   Nelson, Laura E ^b   Franks, Nick ^b   Maze, Mervyn ^b   Chamberlin, Nancy L ^a   Saper, Clifford B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Antinociception; Sedation; Supraspinal analgesia; Tail flick

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; ALCOHOL; ANESTHETIC AGENT; CHLORAL HYDRATE; DIZOCILPINE; KETAMINE; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXIDOPAMINE; PENTOBARBITAL; PROTEIN C FOS;

ANESTHESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; AROUSAL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DELTA RHYTHM; DRUG MECHANISM; MALE; MONOAMINERGIC SYSTEM; NERVE PROJECTION; NEUROANATOMY; NOCICEPTIVE STIMULATION; NONHUMAN; NORADRENERGIC SYSTEM; OREXINERGIC SYSTEM; PERIAQUEDUCTAL GRAY MATTER; PREOPTIC NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REM SLEEP; SEDATION; SLEEP WAKING CYCLE; SPINAL CORD; TAIL FLICK TEST; THERMAL STIMULATION; THETA RHYTHM; TISSUE DISTRIBUTION;

ANALGESICS; ANESTHESIA; ANIMALS; ELECTROENCEPHALOGRAPHY; MALE; RATS; RATS, SPRAGUE-DAWLEY; SLEEP; SLEEP STAGES; WAKEFULNESS;

EID: 43249106443     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21685     Document Type: Article

References (80)

1. Abi-Saab WM, D'Souza DC, Moghaddam B, Krystal JH. 1998. The NMDA antagonist model for schizophrenia: promise and pitfalls. Pharmacopsychiatry Suppl 2:104-109.
2. Aston-Jones G. 2005. Brain structures and receptors involved in alertness. Sleep Med Suppl 1:S3-7.
3. Bajic D, Proudfit HK, Van Bockstaele EJ. 2000. Periaqueductal gray neurons monosynaptically innervate extranuclear noradrenergic dendrites in the rat pericoerulear region. J Comp Neurol 427:649-662.
4. Bajic D, Van Bockstaele EJ, Proudfit HK. 2001. Ultrastructural analysis of ventrolateral periaqueductal gray projections to the A7 catecholamine cell group. Neuroscience 104:181-197.
5. Barbaro NM, Hammond DL, Fields HL. 1985. Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat. Brain Res 343:223-229.
6. Brodie MS, Proudfit HK. 1984. Hypoalgesia induced by the local injection of carbachol into the nucleus raphe magnus. Brain Res 291:337-342.
7. Budai D, Harasawa I, Fields HL. 1998. Midbrain periaqueductal gray (PAG) inhibits nociceptive inputs to sacral dorsal horn nociceptive neurons through alpha2-adrenergic receptors. J Neurophysiol 80: 2244-2254.
8. Bytner B, Huang YH, Yu LC, Lundeberg T, Nylander I, Rosen A. 2001. Nociceptin/orphanin FQ into the rat periaqueductal gray decreases the withdrawal latency to heat and loading, an effect reversed by (Nphe(1))nociceptin(1-13) NH(2). Brain Res 922:118-124.
9. Campbell IG, Feinberg I. 1996. NREM delta stimulation following MK-801 is a response of sleep systems. J Neurophysiol 76:3714-3720.
10. Carruba MO, Bondiolotti G, Picotti GB, Catteruccia N, Da Prada M. 1987. Effects of diethyl ether, halothane, ketamine and urethane on sympathetic activity in the rat. Eur J Pharmacol 134:15-24.
11. Chou TC, Bjorkum AA, Gaus SE, Lu J, Scammell TE, Saper CB. 2002. Afferents to the ventrolateral preoptic nucleus. J Neurosci 22:977-990.
12. Chou TC, Scammell TE, Gooley JJ, Gaus SE, Saper CB, Lu J. 2003. Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms. J Neurosci 23:10691-10702.
13. Clark FM, Proudfit HK. 1991. Projections of neurons in the ventromedial medulla to pontine catecholamine cell groups involved in the modulation of nociception. Brain Res 540:105-115.
14. Commons KG, Van Bockstaele EJ, Pfaff DW. 1999. Frequent colocalization of mu opioid and NMDA-type glutamate receptors at postsynaptic sites in periaqueductal gray neurons. J Comp Neurol 408:549-559.
15. Commons KG, Beck SG, Rudoy C, Van Bockstaele EJ. 2001. Anatomical evidence for presynaptic modulation by the delta opioid receptor in the ventrolateral periaqueductal gray of the rat. J Comp Neurol 430:200-208.
16. Corner M, Scholte R, Korf J, Mirmiran M. 1984. Electrocortical activity patterns during chloral hydrate induced sleep in developing rats. Brain Res Bull 12:77-81.
17. Crisp T, Perrotti JM, Smith DL, Stafinsky JL, Smith DJ. 1991. The local monoaminergic dependency of spinal ketamine. Eur J Pharmacol 194: 167-172.
18. Day HE, Masini CV, Campeau S. 2004. The pattern of brain c-fos mRNA induced by a component of fox odor, 2,5-dihydro-2,4,5-trimethylthiazoline (TMT), in rats, suggests both systemic and processive stress characteristics. Brain Res 1025:139-151.
19. Dragunow M, Faull RL. 1990. MK-801 induces c-fos protein in thalamic and neocortical neurons of rat brain. Neurosci Lett 111:39-45.
20. Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA. 1999. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine. Brain Res 843:171-183.
21. Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA. 2000. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism. J Pharmacol Exp Ther 293:8-14.
22. Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M, Saper CB, Scammell TE. 2001. Fos expression in orexin neurons varies with behavioral state. J Neurosci 21:1656-1662.
23. Fields HL, Vanegas H, Hentall ID, Zorman G. 1983. Evidence that disinhibition of brain stem neurones contributes to morphine analgesia. Nature 306:684-686.
24. Foong FW, Satoh M. 1984. The periaqueductal gray is the site of the antinociceptive action of carbamazepine as related to bradykinin-induced trigeminal pain. Br J Pharmacol 83:493-497.
25. Fukuda T, Furukawa H, Hisano S, Toyooka H. 2006. Systemic clonidine activates neurons of the dorsal horn, but not the locus coeruleus (A6) or the A7 area, after a formalin test: the importance of the dorsal horn in the antinociceptive effects of clonidine. J Anesth 20:279-283.
26. Gallopin T, Fort P, Eggermann E, Cauli B, Luppi PH, Rossier J, Audinat E, Mühlethaler M, Serafin M. 2000. Identification of sleep-promoting neurons in vitro. Nature 40:992-995.
27. Gaus SE, Strecker RE, Tate BA, Parker RA, Saper CB. 2002. Ventrolateral preoptic nucleus contains sleep-active, galaninergic neurons in multiple mammalian species. Neuroscience 115:285-294.
28. Gong H, Szymusiak R, King J, Steininger T, McGinty D. 2000. Sleep-related c-Fos protein expression in the preoptic hypothalamus: effects of ambient warming. Am J Physiol Regul Integr Comp Phys 279: R2079-R2088.
29. Jahng JW, Zhang TY, Lee S, Kim DG. 2001. Effects of dextromethorphan on nocturnal behavior and brain c-Fos expression in adolescent rats. Eur J Pharmacol 431:47-52.
30. Jensen TS, Yaksh TL. 1986. Examination of spinal monoamine receptors through which brainstem opiate-sensitive systems act in the rat. Brain Res 363:114-27.
31. Kaiyala KJ, Thiele TE, Watson CH, Ramsay DS. 2003. Nitrous oxide-induced c-Fos expression in the rat brain. Brain Res 967:73-80.
32. Kalyuzhny AE, Wessendorf MW. 1998. Relationship of mu- and delta-opioid receptors to GABAergic neurons in the central nervous system, including antinociceptive brainstem circuits. J Comp Neurol 392:528-547.
33. Kawamata T, Omote K, Sonoda H, Kawamata M, Namiki A. 2000. Analgesic mechanisms of ketamine in the presence and absence of peripheral inflammation. Anesthesiology 93:520-528.
34. Kingery WS, Sawamura S, Agashe GS, Davies MF, Clark JD, Zimmer A. 2001. Enkephalin release and opioid receptor activation does not mediate the antinociceptive or sedative/hypnotic effects of nitrous oxide. Eur J Pharmacol 427:27-35.
35. Kingery WS, Agashe GS, Guo TZ, Sawamura S, Davies MF, Clark JD, Kobilka BK, Maze M. 2002. Isoflurane and nociception: spinal alpha2A adrenoceptors mediate antinociception while supraspinal alpha1 adrenoceptors mediate pronociception. Anesthesiology 96:367-374.
36. A agonist THIP (gaboxadol) increases non-REM sleep and enhances delta activity in the rat. Neuroreport 7:2241-2245.
37. Lancel M, Faulhaber J, Schiffelholz T, Mathias S, Deisz RA. 1997. Muscimol and midazolam do not potentiate each other's effects on sleep EEG in the rat. J Neurophysiol 77:1624-1629.
38. Levy RA, Proudfit HK. 1979. Analgesia produced by microinjection of baclofen and morphine at brain stem sites. Eur J Pharmacol 57:43-55.
39. Lichtman AH, Cook SA, Martin BR. 1996. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement. J Pharmacol Exp Ther 276: 585-593.
40. Lin JS, Sakai K, Vanni-Mercier G, Jouvet M. 1989. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res 479: 225-240.
41. Lu J, Greco MA, Shiromani P, Saper CB. 2000. Lesions of ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci 20:3830-3842.
42. Lu J, Zhang YH, Chou T, Gaus SG, Shiromani P, Saper CB. 2001. Contrasting effects of ibotenate lesions of the paraventricular nucleus and subparaventricular zone on sleep-wake cycle and temperature regulation. J Neurosci 21:4864-4874.
43. Lu J, Bjorkum AA, Xu M, Gaus SG, Shiromani P, Saper CB. 2002. Selective activation of the extended ventrolateral preoptic nucleus during REM sleep. J Nueorsci 22:4568-4576.
44. Lu J, Jhou TC, Saper CB. 2006. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J Neurosci 26:193-202.
45. Ma S, Morilak DA. 2004. Induction of FOS expression by acute immobilization stress is reduced in locus coeruleus and medial amygdala of Wistar-Kyoto rats compared with Sprague-Dawley rats. Neuroscience 124:963-972.
46. Marquis KL, Gussio R, Webb MG, Moreton JE. 1989. Cortical EEG changes during the self-administration of phencyclinoids. Neuropharmacology 28:1193-1198.
47. Martin WJ, Gupta NK, Loo CM, Rohde DS, Basbaum AI. 1999. Differential effects of neurotoxic destruction of descending noradrenergic pathways on acute and persistent nociceptive processing. Pain 80:57-65.
48. Mattia A, Moreton JE. 1986. Electroencephalographic (EEG), EEG power spectra, and behavioral correlates in rats given phencyclidine. Neuropharmacology 25:763-769.
49. Mendelson WB. 1996. Sleep induction by microinjection of pentobarbital into the medial preoptic area in rats. Life Sci 59:1821-1828.
50. Millan MJ. 2002. Descending control of pain. Prog Neurobiol 66:355-474.
51. Mitchell JM, Lowe D, Fields HL. 1998. The contribution of the rostral ventromedial medulla to the antinociceptive effects of systemic morphine in restrained and unrestrained rats. Neuroscience 87:123-133.
52. Miyamoto S, Leipzig JN, Lieberman JA, Duncan GE. 2000. Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice. Neuropsychopharmacology 22:400-412.
53. Moghaddam B. 1994. Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 18:859-870.
54. Nassif S, Kempf E, Cardo B, Velley L. 1983. Neurochemical lesion of the locus coeruleus of the rat does not suppress the sedative effect of clonidine. Eur J Pharmacol 91:69-76.
55. Nassif-Caudarella S, Kempf E, Velley L. 1986. Clonidine-induced sedation is not modified by single or combined neurochemical lesions of the locus coeruleus, the median and dorsal raphe nuclei. Pharmacol Biochem Behav 25:1211-1216.
56. A receptors in an endogenous sleep pathway. Nat Neurosci 5:979-984.
57. Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M. 2003. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 98:428-436.
58. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates. San Diego: Academic Press.
59. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS. 1998. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996-10015.
60. A receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol 44:475-498.
61. Sagratella S, Pezzola A, Popoli P, Scotti de Carolis AS. 1992. Different capability of N-methyl-D-aspartate antagonists to elicit EEG and behavioural phencyclidine-like effects in rats. Psychopharmacology 109: 277-282.
62. Sawamura S, Kingery WS, Davies MF, Agashe GS, Clark JD, Kobilka BK, Hashimoto T, Maze M. 2000. Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of α2B adrenoceptors. J Neurosci 20:9242-9251.
63. Sawynok J. 1987. GABAergic mechanisms of analgesia: an update. Pharmacol Biochem Behav 26:463-474.
64. Sawynok J, Reid A. 1987. Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia. Brain Res 419:156-165.
65. Sharp JW. 1997. Phencyclidine (PCP) acts at sigma sites to induce c-fos gene expression. Brain Res 758:51-58.
66. Sherin JE, Shiromani PJ, McCarley RW, Saper CB. 1996. Activation of ventrolateral preoptic neurons during sleep. Science 271:216-219.
67. Sloan TB. 1998. Anesthetic effects on electrophysiologic recordings. J Clin Neurophysiol 15:217-226.
68. Suntsova N, Szymusiak R, Alam MN, Guzman-Marin R, McGinty D. 2002. Sleep-waking discharge patterns of median preoptic nucleus neurons in rats. J Physiol 543:665-677.
69. Tomemori N, Komatsu T, Shingu K, Urabe N, Seo N, Mori K. 1981. Activation of the supraspinal pain inhibition system by ketamine hydrochloride. Acta Anaesthesiol Scand 25:355-359.
70. Vaccarino AL, Clemmons HR, Mader GJ Jr, Magnussen JE. 1997. A role of periaqueductal grey NMDA receptors in mediating formalin-induced pain in the rat. Neurosci Lett 236:117-119.
71. Vaughan CW, Ingram SL, Christie MJ. 1997a. Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J Neurosci 17:996-1003.
72. Vaughan CW, Ingram SL, Connor MA, Christie MJ. 1997b. How opioids inhibit GABA-mediated neurotransmission. Nature 390:611-614.
73. Verret L, Goutagny R, Fort P, Cagnon L, Salvert D, Léger L, Boissard R, Salin P, Peyron C, Luppi PH. 2003. A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci 9;4:19.
74. Wang H, Wessendorf MW. 2002. Mu- and delta-opioid receptor mRNAs are expressed in periaqueductal gray neurons projecting to the rostral ventromedial medulla. Neuroscience 109:619-634.
75. Westlund KN, Craig AD. 1996. Association of spinal lamina I projections with brainstem catecholamine neurons in the monkey. Exp Brain Res 110:151-162.
76. A receptor to periaqueductal grey-raphe magnus projection neurons. J Neurocytol 19:686-696.
77. Yamamura T, Fukuda M, Takeya H, Goto Y, Furukawa K. 1981. Fast oscillatory EEG activity induced by analgesic concentrations of nitrous oxide in man. Anesth Analg 60:283-288.
78. Yeomans DC, Proudfit HK. 1990. Projections of substance P-immunoreactive neurons located in the ventromedial medulla to the A7 noradrenergic nucleus of the rat demonstrated using retrograde tracing combined with immunocytochemistry. Brain Res 532:329-332.
79. Yeung JC, Yaksh TL, Rudy TA. 1977. Concurrent mapping of brain sites for sensitivity to the direct application of morphine and focal electrical stimulation in the production of antinociception in the rat. Pain 4:23-40.
80. Zuniga J, Joseph S, Knigge K. 1987. Nitrous oxide analgesia: partial antagonism by naloxone and total reversal after periaqueductal gray lesions in the rat. Eur J Pharmacol 142:51-60.